Shandong researchers suggest that edible and medicinal fungi contain bioactive components with therapeutic potential for ...

Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - ...

BURLINGTON, Mass., May 13, 2025(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today reported business upd ...

The new agreement with Blackstone simultaneously expands our total available credit facility by more than $200 million, and significantly reduces our cost of capital,” said Herriot Tabuteau, MD, Chief ...

Suven Life Sciences hit a record high of ₹175, surging 15 per cent today, as the Board approved a fundraising plan of ₹857.64 ...

Neurological disorders, including neurosurgical conditions and various neurological diseases, are often associated with ...

Reviva's current pipeline focuses on the central nervous system (CNS), inflammatory and cardiometabolic diseases. Reviva's pipeline currently includes two drug candidates, brilaroxazine (RP5063) and ...